LA RAMEE BIO : revenue, balance sheet and financial ratios

LA RAMEE BIO is a French company founded 18 years ago, specialized in the sector Autres commerces de détail alimentaires en magasin spécialisé . Based in TOURNEFEUILLE (31170), this company of category PME shows in 2025 a revenue of 2.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-07-11

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Synthèse

Santé financière : Saine

Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.

In summary, LA RAMEE BIO posts positive profitability over the latest financial year. Its financial structure is broadly in line with its sector.

Financial history - LA RAMEE BIO (SIREN 499665446)
Indicator 2025 2024 2023 2021 2020 2018 2017 2016
Revenue 2 890 577 € 2 819 596 € 2 727 232 € 3 420 364 € 3 089 044 € 2 749 772 € 2 904 572 € 2 754 599 €
Net income 128 598 € 141 701 € 127 776 € 211 454 € 153 266 € 62 474 € 145 162 € 197 793 €
EBITDA 197 801 € 218 822 € 191 516 € 311 542 € 266 335 € 90 069 € 237 051 € 307 224 €
Net margin 4.4% 5.0% 4.7% 6.2% 5.0% 2.3% 5.0% 7.2%

Revenue and income statement

In 2025, LA RAMEE BIO achieves revenue of 2.9 M€. Activity remains stable over the period (CAGR: -1.3%). Vs 2024: +3%. After deducting consumption (2.0 M€), gross margin stands at 930 k€, i.e. a rate of 32%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 198 k€, representing 6.8% of revenue. This ratio is more favorable than the sector median (5.2%). Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 129 k€, i.e. 4.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

2 890 577 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

929 615 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

197 801 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

163 808 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

128 598 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

6.8%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 49%. This ratio is slightly less favorable than the sector median (17.2%). Financial autonomy (= Equity / Total assets x 100) reaches 39%. This ratio is slightly less favorable than the sector median (41.5%). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.9 years of cash flow to repay all financial debt. This ratio is slightly less favorable than the sector median (0.5 years). Cash flow represents 5.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This ratio is more favorable than the sector median (4.0%).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

48.91%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

39.49%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

5.61%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.93

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

12.3%

Solvency indicators evolution
LA RAMEE BIO

Sector positioning

Debt ratio
48.91% 2025
Q1: 1.86%
Med: 17.22%
Q3: 50.64%
Average +36 pts over 3 years

In 2025, the debt ratio of LA RAMEE BIO (48.9%) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
39.49% 2025
Q1: 15.39%
Med: 41.51%
Q3: 61.41%
Average -25 pts over 3 years

In 2025, the financial autonomy of LA RAMEE BIO (39.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.93 years 2025
Q1: 0.01 years
Med: 0.48 years
Q3: 2.08 years
Average +10 pts over 3 years

In 2025, the repayment capacity of LA RAMEE BIO (0.93) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1.79. This ratio is more favorable than the sector median (1.8). The interest coverage ratio (= EBIT / Interest expenses) is 2.5x. This ratio is more favorable than the sector median (0.9x).

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1.79

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

2.45

Liquidity indicators evolution
LA RAMEE BIO

Sector positioning

Liquidity ratio
1.79 2025
Q1: 1.11
Med: 1.79
Q3: 2.8
Good

In 2025, the liquidity ratio of LA RAMEE BIO (1.79) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
2.45x 2025
Q1: 0.0x
Med: 0.94x
Q3: 4.71x
Good +9 pts over 3 years

In 2025, the interest coverage of LA RAMEE BIO (2.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 39 days. Excellent situation: suppliers finance 39 days of the operating cycle (retail model). Inventory turnover is 15 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 16 days of revenue, i.e. 132 k€ to permanently finance.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

132 388 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

39 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

15 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

16 j

WCR and payment terms evolution
LA RAMEE BIO

Positioning of LA RAMEE BIO in its sector

Comparison with sector Autres commerces de détail alimentaires en magasin spécialisé

Valuation estimate

Based on 300 transactions of similar company sales (all years), the value of LA RAMEE BIO is estimated at 914 142 € (range 437 075€ - 1 628 511€). With an EBITDA of 197 801€, the sector multiple of 4.7x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
300 transactions
437k€ 914k€ 1628k€
914 142 € Range: 437 075€ - 1 628 511€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
197 801 € × 4.7x
Estimation 937 161 €
408 949€ - 1 693 306€
Revenue Multiple 30%
2 890 577 € × 0.36x
Estimation 1 044 442 €
566 838€ - 1 693 072€
Net Income Multiple 20%
128 598 € × 5.1x
Estimation 661 145 €
312 750€ - 1 369 683€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 300 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Autres commerces de détail alimentaires en magasin spécialisé )

Compare LA RAMEE BIO with other companies in the same sector:

Voir toutes les statistiques du secteur Autres commerces de détail alimentaires en magasin spécialisé

Top companies in Autres commerces de détail alimentaires en magasin spécialisé

Largest companies by revenue in the sector Autres commerces de détail alimentaires en magasin spécialisé :

Top companies in Haute-Garonne

Largest companies by revenue in the department Haute-Garonne:

Voir le classement complet du département Haute-Garonne

Frequently asked questions about LA RAMEE BIO

What is the revenue of LA RAMEE BIO ?

The revenue of LA RAMEE BIO in 2025 is 2.9 M€.

Is LA RAMEE BIO profitable?

Yes, LA RAMEE BIO generated a net profit of 129 k€ in 2025.

Where is the headquarters of LA RAMEE BIO ?

The headquarters of LA RAMEE BIO is located in TOURNEFEUILLE (31170), in the department Haute-Garonne.

Where to find the tax return of LA RAMEE BIO ?

The tax return of LA RAMEE BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LA RAMEE BIO operate?

LA RAMEE BIO operates in the sector Autres commerces de détail alimentaires en magasin spécialisé (NAF code 47.29Z). See the 'Sector positioning' section above to compare the company with its competitors.